143
Views
0
CrossRef citations to date
0
Altmetric
Review

The importance of malapposition in angiographically optimized stenting in contemporaneous interventions

&
Pages 599-605 | Received 30 Mar 2018, Accepted 22 Jun 2018, Published online: 12 Jul 2018

References

  • Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guidelines for percutaneous coronary intervention. J Am Coll Cardiol. 2011 Dec 6;58:e44–e122. PubMed PMID: 22070834.
  • Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995 Mar 15;91:1676–1688. PubMed PMID: 7882474.
  • Guo N, Maehara A, Mintz GS, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation. 2010 Sep 14;122:1077–1084.
  • Romagnoli E, Gatto L, La Manna A, et al. Role of residual acute stent malapposition in percutaneous coronary interventions. Catheter Cardiovasc Interv. 2017 Oct 1;90:566–575.
  • Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012 Mar 20;59:1058–1072. PubMed PMID: 22421299.
  • Steinberg DH, Mintz GS, Mandinov L, et al. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May;3:486–494. PubMed PMID: 20488404.
  • Van Der Hoeven BL, Liem SS, Dijkstra J, et al. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study. JACC Cardiovasc Interv. 2008 Apr;1:192–201. PubMed PMID: 19463300.
  • Bouma BE, Tearney GJ, Yabushita H, et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart. 2003 Mar;89:317–320. PubMed PMID: 12591841; PubMed Central PMCID: PMCPMC1767586.
  • Ozaki Y, Okumura M, Ismail TF, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010 Jun;31:1470–1476. PubMed PMID: 20363765.
  • Im E, Kim BK, Ko YG, et al. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv. 2014 Feb;7:88–96. PubMed PMID: 24425586.
  • Agrawal M, Hakeem A, Ahmed Z, et al. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: an optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 1;90:225–232.
  • Kubo T, Imanishi T, Kitabata H, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging. 2008 Jul;1:475–484. PubMed PMID: 19356470.
  • Hong MK, Park SW, Lee CW, et al. Intravascular ultrasound comparison of chronic recoil among different stent designs. Am J Cardiol. 1999 Nov 15;84:1247–1250, A8. PubMed PMID: 10569337.
  • Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006 Jan 24;113:414–419. PubMed PMID: 16432073.
  • Minami Y, Ong DS, Uemura S, et al. Impacts of lesion angle on incidence and distribution of acute vessel wall injuries and strut malapposition after drug-eluting stent implantation assessed by optical coherence tomography. Eur Heart J Cardiovasc Imaging. 2015 Dec;16:1390–1398. PubMed PMID: 25925215.
  • Chen WX, Poon EKW, Thondapu V, et al. Haemodynamic effects of incomplete stent apposition in curved coronary arteries. J Biomech. 2017 Oct 3;63:164–173. PubMed PMID: 29032800.
  • Kawamori H, Shite J, Shinke T, et al. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur Heart J Cardiovasc Imaging. 2013 Sep;14:865–875. PubMed PMID: 23291393; PubMed Central PMCID: PMCPMC3738096.
  • Guagliumi G, Bezerra HG, Sirbu V, et al. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv. 2012 Feb 1;5:30–38. PubMed PMID: 22298797.
  • Izumi D, Miyahara M, Fujimoto N, et al. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation. Heart Vessels. 2016 Aug;31:1247–1256. PubMed PMID: 26334709.
  • Inoue T, Shinke T, Otake H, et al. Impact of strut-vessel distance and underlying plaque type on the resolution of acute strut malapposition: serial optimal coherence tomography analysis after everolimus-eluting stent implantation. Int J Cardiovasc Imaging. 2014 Jun;30:857–865. PubMed PMID: 24748583.
  • Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987 May 28;316:1371–1375. PubMed PMID: 3574413.
  • Alfonso F, Dutary J, Paulo M, et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart. 2012 Aug;98:1213–1220. PubMed PMID: 22826559.
  • Guagliumi G, Sirbu V, Musumeci G, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012 Jan;5:12–20. PubMed PMID: 22230145.
  • Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005 Feb 22;111:900–905. PubMed PMID: 15710761.
  • Soeda T, Uemura S, Park SJ, et al. Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry. Circulation. 2015 Sep 15;132:1020–1029. PubMed PMID: 26162917.
  • Wang B, Mintz GS, Witzenbichler B, et al. Predictors and long-term clinical impact of acute stent malapposition: an assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) intravascular ultrasound substudy. J Am Heart Assoc. 2016 Dec 22;5. PubMed PMID: 28007741; PubMed Central PMCID: PMCPMC5210413. DOI: 10.1161/JAHA.116.004438
  • Prati F, Romagnoli E, Burzotta F, et al. Clinical impact of OCT findings during PCI: the CLI-OPCI II study. JACC Cardiovasc Imaging. 2015 Nov;8:1297–1305. PubMed PMID: 26563859.
  • Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004 Feb 24;109:881–886. PubMed PMID: 14967732.
  • Karalis I, Ahmed TA, Jukema JW. Late acquired stent malapposition: why, when and how to handle? Heart. 2012 Oct;98:1529–1536. PubMed PMID: 23001063.
  • Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv. 2010 May;3:531–539. PubMed PMID: 20488410.
  • Kubo T, Akasaka T, Kozuma K, et al. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). EuroIntervention. 2015 Sep;11:564–571. PubMed PMID: 26390517.
  • Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007 May 8;115:2426–2434.
  • Cook S, Eshtehardi P, Kalesan B, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J. 2012 Jun;33:1334–1343. Epub 2012 Jan 26. PubMed PMID: 22285579.
  • Sethi A, Singbal Y, Rastogi U, et al. Late incomplete stent apposition is associated with late/very late stent thrombosis: a meta-analysis. Catheter Cardiovasc Interv. 2018 Feb 15;91:365–375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.